Effects of selective I f-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy.
Wenzel
Philip
P
Universitätsmedizin der Johannes-Gutenberg-Universität Mainz, II. Medizinische Klinik-Kardiologie, Angiologie und Internistische Intensivmedizin, Langenbeckstrasse 1, Mainz, Germany. wenzelp@uni-mainz.de
Abegunewardene
Nico
N
Münzel
Thomas
T
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use*; D002313:Cardiomyopathy, Restrictive / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D054815:Cyclic Nucleotide-Gated Cation Channels / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004452:Echocardiography; D015716:Electrocardiography, Ambulatory; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D000077550:Ivabradine; D008279:Magnetic Resonance Imaging; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D054815:Cyclic Nucleotide-Gated Cation Channels; D000077550:Ivabradine